Evaluating the Glycemic Effects of Dolutegravir and Its Predictors Among People With Human Immunodeficiency Virus in Uganda: A Prospective Cohort Study.
Ankunda C, Agolor C, Karamagi Y, Nakubulwa S, Namasambi S, Kasamba I, Christopher SM, Kukundakwe P, Odiit M, Mubangizi I, Emunyu J, Kesi DN, Nambasa V, Ndagije HB, Mukasa B.
Ankunda C, et al. Among authors: ndagije hb.
Open Forum Infect Dis. 2024 Oct 8;11(10):ofae596. doi: 10.1093/ofid/ofae596. eCollection 2024 Oct.
Open Forum Infect Dis. 2024.
PMID: 39450397
Free PMC article.